Session Details

Dementia

Tuesday, 10 February 2004 14:30 -16:45

Promenade Meeting Room 4

Co-Chair MD, PhD Birgitta Näsman Umeå UniversitySweden
Co-Chair Prof David J Wyper South Glasgow Glasgow University Hospitals NHS TrustUnited Kingdom

Late-onset depression with mild cognitive deficits: A preclinical dementia syndrome?
  • Stefanie Brassen, NeuroImage Nord, Hamburg, Germany
  • Is there a difference in encoding memory processes between mild Alzheimer´s disease and healthy elderly using rCBF 99mTc-HMPAO SPET?
  • MD, PhD Birgitta Näsman, Umeå University, Sweden
  • Neural function of cognition deficits in Alzheimer’s disease - A PET study of resting cerebral glucose metabolism
  • Dr Peter Schoenknecht, Ruprecht-Karls-University, Germany
  • Resting brain glucose metabolism and cerebrospinal fluid tau protein in the clinical diagnosis of Alzheimer's disease
  • Dr Aoife M Hunt, Psychiatric University Hospital, Heidelberg, Germany
  • CSF estrogen levels are correlated with Hippocampal glucose metabolism in female patients with Alzheimer’s disease
  • Peter Schoenknecht, Ruprecht-Karls-University, Germany
  • Memory enhancing effects of Salvia officinalis (sage): Potential treatment for cognitive decline
  • Dr David O Kennedy, Human Cognitive Neuroscience Unit, Northumbria University, United Kingdom
  • Cognitive effects of ginkgo biloba alone and in combination with Phosphatidylserine
  • Crystal F Haskell, Northumbria University, United Kingdom
  • Evidence that cholinesterase inhibition produces a greater cognitive improvement in AD patients with a more established cholinergic deficit
  • Prof David J Wyper, South Glasgow Glasgow University Hospitals NHS Trust, United Kingdom
  • The neuroprotective effect of cdp-choline
  • Nuria Durany, International University of Catalonia, Spain